Proactive Investors - Run By Investors For Investors

Tissue Regenix boss to return to full-time duties in June

Steve Couldwell has been out of action so far this year while he undergoes medical treatment
Steve Couldwell
Despite Couldwell’s absence, TRX has “continued to develop in line with expectations”

The chief executive of Tissue Regenix Group PLC (LON:TRX) is to return to full-time duties next month.

At the end of last year, the regenerative medicines specialist confirmed Steve Couldwell would be taking a temporary leave of absence to undergo medical treatment.

READ: Tissue Regenix secures additional coverage for DermaPure from US GPO

“The board and I look forward to welcoming Steve back into the full time CEO position and are grateful for his ongoing commitment,” said chairman John Samuel, who held the fort whilst Couldwell was away.

“During his necessary absence Steve remained in daily contact with the business and continued to be integral to implementing the business strategy and establishing future business developments, along with the support of Gareth Jones who undertook the chief operating officer role during this period.”

Samuel added: “The business has continued to develop in line with the board expectations.”

View full TRX profile View Profile

Tissue Regenix Group PLC Timeline

Related Articles

cancerous cells
April 15 2019
The company’s cancer treatment is based on work undertaken by John Beard, a professor of embryology at Edinburgh University nearly 100 years ago
human kidneys
May 06 2019
The Danish company is seeking FDA approval of the test for use in both adults and children
February 01 2019
The cancer detection device is on track to finish a key clinical study in the first quarter of 2019, but in the meantime, it has shown promise in detecting abnormalities in unborn children

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use